News from NORD

Running Marathons to Advance Rare Disease Awareness and Diagnosis


 

Running for Rare, NORD’s signature charity marathon team, participated as an official charity partner in the Tata Consultancy Services (TCS) New York City Marathon in November. The team participates in several marathons and half-marathons each year to raise funds for NORD’s program for undiagnosed patients. Specifically, the NORD program provides financial assistance for medical testing required of applicants to the Undiagnosed Diseases Network (UDN).

Each runner on the team is paired with a rare disease patient partner. Runners and their partners provide inspiration to each other and promote awareness of specific rare diseases. They also raise funds for the NORD Patient Assistance Program, to which undiagnosed patients are referred by staff at clinical centers affiliated with the UDN.

The team has planned an ambitious season for 2017 beginning with the Los Angeles Marathon on March 19. Runners interested in joining the team can learn more on the NORD website .

Recommended Reading

Follow-Up of Infants With Zika Virus Identifies Several Neurologic Impairments
MDedge Neurology
NORD Urges Congress to Pass 21st Century Cures Act
MDedge Neurology
Nominate a Colleague for a NORD 2017 Rare Impact Award
MDedge Neurology
FDA Awards 21 Grants for Rare Disease Product Development
MDedge Neurology
Free Genetic Testing Program Is Launched for Patients With Inherited Retinal Diseases
MDedge Neurology
Undiagnosed Diseases Network Seeks Patients With Similar Symptoms
MDedge Neurology
MAPRx Publishes Its Annual Guide for Medicare Part D Open Enrollment
MDedge Neurology
VHL Alliance Publishes Suggested VHL Surveillance Guidelines
MDedge Neurology
What’s New in Rare Neuromuscular Disorders?
MDedge Neurology
The Journey to an FTD Diagnosis Webinar Now Available
MDedge Neurology